SCHEMBL21872420

SCHEMBL21872420

Cc1cc(C=N)c(NCC(C)(C)C)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21872491 0.88 IL1B (0.34) —
SCHEMBL21872806 0.84 — —
SCHEMBL24900934 0.82 — —
SCHEMBL21872459 0.82 — —
SCHEMBL21872399 0.76 — —
SCHEMBL21872448 0.76 — —
SCHEMBL21872860 0.75 — —
SCHEMBL21936263 0.74 LMNA (0.30) —
SCHEMBL21936271 0.71 — —
SCHEMBL25687871 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632897-A1 NOVEL BIPHENYL COMPOUND OR SALT THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 — — EP disclosed
EP-3633380-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 — — EP disclosed
Send feedback